Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
Centessa Pharmaceuticals | DEF 14A: Definitive information statements
Centessa Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Centessa Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | DEFA14A: Others
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | DEF 14A: Definitive information statements
No Data